Research related to metastatic cancer is gradually gaining momentum in recent times. Several research organisations, institutes, and entities are making efforts to develop effective treatments for metastatic cancer. A team of researchers at University of Georgia have developed a new technique to understand this form of cancer. Further, the researchers have built a micro-fluidic device to study metastatic cancer in humans. The device works on the principle of separating useful materials from toxic ones. This device can separate tumour cells circulating in the blood. As a result, this can help prevent the tumour cells from spreading in the body.
Preventing Growth of Tumours
Circulating tumour cells (CTCs) disband from the blood and travel to other parts of the blood stream. As a result, new tumours form in other parts of the body. The newly developed device helps in isolating the CTCs from the blood stream. As a result, this nullifies the negative impact of the circulating tumour cells in the body. Moreover, the device can help in finding new treatment lines for breast cancer. This is a key consideration for cancer researchers, oncologists, and other medical experts.
Defining Treatment Lines
The most distinct feature of the device is its ability to track the response of treatment lines. In other words, the device can help in gauging the impact of a particular treatment in different individuals. This shall in turn help in finding the most apt line of treatment for metastatic cancer. The device is being hailed as a revolutionary development in the field of oncology.